Chief Accounting Officer of $DBX sells 1,066 shares in insider sale

The Chief Accounting Officer of $DBX, Sarah Elizabeth Schubach, recently sold 1,066 shares of the company on September 15, 2025, for about $32,907 as reported in a recent SEC filing. This sale amounted to roughly 1.0% of her holdings of this class of stock, leaving her with 106,789 shares of $DBX stock.

Insider trading activity within $DBX has been quite active in the past 6 months, with insiders completing 37 trades on the open market. Interestingly, all 37 of these trades were sales, with 0 being purchases. Among the executives who sold shares are Andrew Houston, the Chief Executive Officer, who sold 640,835 shares worth an estimated $18,219,425, and Timothy Regan, the Chief Financial Officer, who sold 49,000 shares for $1,366,658. Other notable executives include Ashraf Alkarmi, Ali Dasdan, William T Yoon, Karen Peacock, Abhay Parasnis, Lisa M Campbell, Eric Cox, and Andrew William Moore, all of whom executed sales ranging from 2,339 to 30,196 shares with a cumulative estimated sum in the range of tens of thousands to millions of dollars.

In terms of hedge fund activity, 230 institutional investors have added $DBX stock to their portfolios, while 276 have reduced their positions in the most recent quarter. Some significant moves include Ameriprise Financial Inc decreasing their holdings by 58.2% in Q2 2025, Caisse de Depot et Placement du Quebec reducing their portfolio by 73.8%, Morgan Stanley adding 1,786,289 shares, BlackRock, Inc. removing 1,785,274 shares, Voya Investment Management LLC cutting their positions by 82.3%, FMR LLC increasing their shares by 36.2%, and Voloridge Investment Management, LLC fully divesting their 1,290,958 shares in Q2 2025.

Congressional stock trading involving $DBX has shown activity with 2 trades in the past 6 months, out of which 1 was a purchase and 1 was a sale made by Representative Lisa C. McClain. Analysts have recently provided price targets for $DBX, with a median target of $31.0. Notable analysts include Taylor McGinnis from UBS setting a target price of $29.0 and Steven Enders from Citigroup setting a target price of $32.0.

It’s important to note that the information provided is not financial advice and readers should refer to Quiver Quantitative’s disclaimers for more information. Keep track of insider transactions and hedge fund activities by using Quiver Quantitative’s insider trading and institutional holdings dashboards.